India AI in Medical Diagnostics Market By Component (Software, Hardware, Services), By Diagnosis Type (Cardiology, Oncology, Pathology, Radiology, Chest and Lung, Neurology, Others), By Region, Competition, Forecast & Opportunities, 2020-2030F

Market Overview

The India AI in Medical Diagnostics Market was valued at USD 12.87 million in 2024 and is expected to reach USD 44.87 million by 2030, with a CAGR of 23.10% during the forecast period.

The AI in Medical Diagnostics Market in India is witnessing rapid growth, driven by an increasing demand for early and accurate disease detection, a rising burden of chronic illnesses, and a shortage of skilled healthcare professionals. 

With a growing reliance on AI-powered radiology, pathology, and predictive analytics, hospitals and diagnostic centers are integrating AI solutions to enhance efficiency and reduce turnaround times. The market is further fueled by government initiatives, such as the Ayushman Bharat Digital Mission (ABDM) and the National Digital Health Mission (NDHM), which promote healthcare digitization and the adoption of AI. 

India's thriving health-tech startup ecosystem, led by companies such as Qure.ai, Niramai, and Predible Health, is accelerating innovation in AI-based diagnostic imaging and automation.

The Southern region, particularly Bangalore, Chennai, and Hyderabad, dominates the market due to its strong IT infrastructure, top-tier hospitals, and AI research facilities. However, challenges persist, including high costs of AI implementation, a lack of standardization in AI regulations, and concerns over data privacy and patient confidentiality. 

Moreover, the limited adoption of AI in rural healthcare facilities poses a barrier to widespread deployment. Despite these challenges, the increasing availability of cloud-based AI solutions, growing adoption of telemedicine, and ongoing regulatory developments are expected to drive further expansion of AI in medical diagnostics across India.

Key Market Drivers

Rising Healthcare Demand and Disease Burden

India’s healthcare system is facing mounting pressure from the combined weight of chronic disease, population aging, and the growing expectation of earlier diagnosis, which is why AI driven diagnostics are moving from pilot use cases toward mainstream clinical relevance in areas such as radiology, ophthalmology, cardiology, and kidney care.

The Ministry of Health and Family Welfare states that non communicable diseases account for 63 percent of all deaths in India, with about 54.5 million cardiovascular disease cases, 65 million diabetes cases, 55 million COPD cases, 38 million asthma cases, and an annual cancer incidence of 13.92 lakh, all of which create strong demand for tools that can speed up screening, prioritization, and interpretation across large patient volumes.

This burden makes AI especially valuable because healthcare providers need faster triage, earlier detection of complications, and more consistent interpretation of scans and clinical signals without adding proportionately to already stretched specialist workloads. The same government guidelines also emphasize technology enabled interventions, information systems, and early diagnosis as core NP NCD strategies, showing that AI is increasingly aligned with India’s public health direction rather than remaining only a private sector innovation theme.

Shortage of Skilled Healthcare Professionals

India also faces a meaningful shortage and uneven distribution of skilled healthcare professionals, and this problem is particularly serious in diagnostics because high quality interpretation in radiology, pathology, cardiology, and specialized screening often depends on expertise that is concentrated in major urban centres rather than evenly available across tier 2 cities, tier 3 towns, and rural districts.

NITI Aayog’s healthcare focused AI framework specifically identifies the shortage of qualified healthcare professionals, non uniform accessibility to healthcare, affordability constraints, and a reactive approach to essential care as structural challenges that AI can help address, which is important because these gaps directly affect how quickly patients can be screened, diagnosed, and referred.

In practice, AI powered tools can reduce some of this pressure by pre reading medical images, flagging suspicious findings, automating workflow prioritization, and supporting clinicians with decision assistance, thereby improving turnaround time while reducing dependence on scarce specialists for every first level assessment. This does not eliminate the need for doctors, but it makes specialist time more productive and extends quality support to facilities that may not have full diagnostic teams on site, especially when connected through India’s growing digital health backbone.

For instance, Qure.ai’s India linked impact reporting highlights deployment in public health programmes and partnerships that have already reached more than 1,00,000 individuals across 130 plus health facilities in 20 states for TB related screening support, showing how AI can help narrow human resource gaps by bringing consistent, scalable interpretation tools closer to underserved populations.

Growing Investments in AI Healthcare Technology

Rising investment in AI healthcare technology is becoming another major driver in India because innovation is now being supported simultaneously by startup scale up, multinational participation, digital public infrastructure, and government policy frameworks that make clinical data exchange and technology deployment more practical than before.

The Ayushman Bharat Digital Mission is designed to build the backbone of an integrated digital health infrastructure that connects digital health solutions of hospitals across the country, enables longitudinal digital records, and supports digital consultation and interoperable data flows, all of which are foundational for scaling AI enabled diagnostics and hospital decision support. NITI Aayog’s national AI strategy also placed healthcare among the priority sectors and explicitly linked AI to solving India’s shortage of qualified professionals, accessibility gaps, and affordability challenges, which has helped create policy confidence around diagnostic use cases instead of treating them as isolated experiments.

Private capital is also reinforcing this direction, with the World Economic Forum noting that India’s healthcare innovation ecosystem saw a 24 percent increase in funding in 2024 and that 2025 was on track to surpass that level, reflecting stronger investor conviction in digital and AI led care models.

Download Free Sample Report

Key Market Challenges

Data Privacy and Security Concerns

One of the biggest challenges in India's AI-driven medical diagnostics market is ensuring data privacy and security. AI-driven diagnostics rely heavily on patient data, including medical records, imaging scans, genetic information, and real-time health monitoring, making data protection a critical concern. 

The healthcare industry in India is still in the early stages of implementing robust data protection regulations, and the absence of a comprehensive legal framework raises concerns about unauthorized access, data breaches, and misuse of sensitive medical information.

With the increasing adoption of cloud-based AI solutions for diagnostics, patient data is often stored and processed on third-party servers, which can pose risks if stringent encryption and cybersecurity measures are not in place. A significant concern is the potential for cyberattacks on healthcare databases, which could result in the theft of sensitive patient information. India has witnessed a rise in cyberattacks on healthcare institutions, with over 1.9 million cyberattacks reported in the healthcare sector in 2022 alone, underscoring the urgent need for improved data protection mechanisms.

Another critical issue is patient consent and data ownership. Many AI-powered diagnostic tools collect, analyze, and learn from patient data to improve accuracy; however, concerns arise regarding who owns this data and how it is utilized. Patients often lack clarity on how their medical information is shared, stored, and utilized for AI training models, which raises ethical and legal concerns. The introduction of India's Digital Personal Data Protection (DPDP) Act, 2023, aims to strengthen data security measures, but its implementation in the healthcare sector remains a work in progress.

Moreover, the lack of standardization in AI regulations across hospitals, diagnostic centers, and research institutions adds complexity to ensuring data security and interoperability. Without clear guidelines on AI integration and data protection, hospitals and AI developers face challenges in complying with multiple regulations, which could potentially slow down AI adoption.

Key Market Trends

Technological Advancements and Startups

India’s AI driven medical diagnostics ecosystem is advancing quickly because the country is dealing with a large and persistent chronic disease burden while also trying to improve speed, accuracy, and affordability in diagnosis across both urban and underserved settings. The Ministry of Health and Family Welfare states that non communicable diseases account for 63 percent of all deaths in India, and its operational framework highlights very large case loads in cardiovascular disease, diabetes, cancer, COPD, and asthma, which is exactly the kind of clinical environment where machine learning, deep learning, and computer vision tools can help triage patients earlier and support faster treatment decisions.

This pressure has created room for a vibrant startup base, with companies such as Qure.ai, Niramai, and Tricog building AI solutions for radiology, breast cancer screening, tuberculosis, stroke, and cardiac care that are designed to work within India’s real world constraints of uneven specialist access and delayed reporting. Government backed digital health architecture is also strengthening the foundation for adoption, as the Union Government reported that the Ayushman Bharat Digital Mission had already enabled 799 million digital health IDs, over 410,000 registered healthcare facilities, more than 670,000 registered healthcare professionals, and over 671 million linked health records by August 2025, creating a much stronger base for interoperable and scalable AI deployment.

For instance, Qure.ai says its AI solutions are now used across more than 4,500 sites in over 100 countries and have impacted more than 32 million lives, while Niramai reports that it has conducted over 70,000 screenings in India across more than 150 installations in 29 Indian cities and Tricog says its Human plus AI platform has diagnosed more than 34 million patients and helped save over 1 million lives, together showing that Indian startups are no longer operating only at pilot level but are building measurable clinical scale in diagnostics.

Growing Collaborations Between Healthcare Providers and Tech Companies

Collaborations between healthcare providers and technology companies are becoming a defining trend in India’s AI diagnostics landscape because hospitals, diagnostic networks, and medtech innovators increasingly recognize that adoption works best when clinical expertise, workflow integration, and algorithmic capability are developed together rather than in isolation.

These partnerships are helping AI move into everyday use cases such as stroke triage, ECG interpretation, cancer screening, and remote monitoring, where the value of the technology depends not just on algorithm performance but on how well it fits into care pathways, referral systems, and doctor decision making. This trend is especially relevant in India because specialist availability remains uneven across regions, and collaboration allows large care providers to extend advanced diagnostic support into secondary cities, outreach programs, and lower resource facilities without waiting for specialist staffing to catch up. The partnership model is also improving scalability, since health systems can combine trusted provider brands, existing patient volumes, and digital infrastructure with startup led tools that are faster to build and adapt for specific use cases.

Segmental Insights

Diagnosis Type Insights

Based on Diagnosis Type, Radiology have emerged as the dominating segment in the India AI in Medical Diagnostics Market in 2024. One of the key reasons for radiology’s dominance is the high volume of medical imaging data generated daily. India faces a shortage of radiologists, with approximately one radiologist per 100,000 people, making AI-driven solutions essential for reducing diagnostic backlogs and improving patient outcomes. AI algorithms can process large volumes of radiology scans within seconds, helping radiologists detect abnormalities, prioritize critical cases, and enhance diagnostic accuracy.

Furthermore, the rising prevalence of chronic diseases such as cancer, cardiovascular diseases (CVDs), and lung infections has fueled the demand for AI-powered radiology solutions. For instance, AI-driven chest X-ray analysis is playing a crucial role in early tuberculosis (TB) detection, aligning with India’s National TB Elimination Program (NTEP). Similarly, AI-powered brain imaging tools are helping detect strokes, tumors, and neurodegenerative disorders like Alzheimer's at an early stage.

Download Free Sample Report

Regional Insights

Based on Region, South India has emerged as the dominating region in the India AI in Medical Diagnostics Market in 2024. It is driven by advanced healthcare infrastructure, strong IT and tech ecosystem, high adoption of AI-driven healthcare solutions, and government initiatives supporting digital health transformation. States like Karnataka, Tamil Nadu, Telangana, and Kerala are at the forefront of AI-powered diagnostic adoption, owing to their well-established medical research institutions, AI-focused startups, and collaborations between healthcare providers and technology firms.

One of the key reasons for South India's dominance is Bengaluru's position as India's hub for AI and healthcare innovation. The city is home to leading AI-driven health-tech startups, such as Qure.ai, Niramai, and Tricog Health, which are developing advanced AI-based solutions in radiology, pathology, and diagnostics. Karnataka's supportive policies and incentives for AI research and development further fuel market growth.

South India boasts some of the country's top-tier hospitals and diagnostic centers, including Apollo Hospitals (Chennai), Narayana Health (Bangalore), Manipal Hospitals, and Christian Medical College (Vellore), which are actively integrating AI-based diagnostics into their clinical workflows. AI-powered radiology, pathology automation, and predictive analytics are being increasingly adopted to enhance early disease detection and precision medicine approaches.

Recent Development

• In February 2025, Kauvery Hospitals unveiled its Advanced Heart Failure Centre in Bengaluru and described it as India’s first AI-powered multidisciplinary hub for heart failure care and rehabilitation. The launch took place during the 2nd Edition of the Kauvery Annual Heart Summit 2025, where the hospital said the centre would combine early diagnosis, AI-guided interventions, rehabilitation, and advanced procedures such as TAVR, LVAD/ECMO support, and heart transplantation under one clinical framework.
• In July 2025, Mahajan Imaging & Labs opened a new integrated diagnostics centre in Dwarka, Delhi, featuring India’s first ultra-fast AI-powered MRI scanner, the Excel 3T. The company said the scanner was designed to deliver up to 50% better signal-to-noise ratio and shorten complex cardiac MRI studies, making the launch notable as a diagnostic-imaging innovation that used AI to improve scan speed, image quality, and clinical workflow.
• In October 2025, Philips expanded its collaboration with Nicolab to advance AI-powered stroke care in India by combining Philips’ imaging systems with Nicolab’s StrokeViewer AI platform. The companies said the partnership was intended to strengthen clinical workflows, support faster decision-making, and improve access to stroke diagnosis and treatment, with Nicolab noting that StrokeViewer was the first cloud-based solution in India to receive regulatory clearance for CT perfusion analysis.
• In December 2025, the Armed Forces Medical Services launched India’s first AI-driven community screening programme for diabetic retinopathy in collaboration with AIIMS and the eHealth AI Unit of the Ministry of Health and Family Welfare. The programme was presented as a breakthrough in public-health diagnostics because the platform automates screening, grading, and triaging of retinal images while also generating real-time data on disease prevalence and geographic distribution for earlier detection of diabetes-related vision loss.

Key Market Players

• Microsoft Corporation
• GE HealthCare Technologies Inc.
• Koninklijke Philips N.V.
• Intel Corporation
• Google LLC
• NVIDIA Corporation
• Digital Diagnostics Inc.

Report Scope

In this report, the India AI in Medical Diagnostics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• India AI in Medical Diagnostics Market, By Component:

o   Software

o   Hardware

o   Services

• India AI in Medical Diagnostics Market, By Diagnosis Type:

o   Cardiology

o   Oncology

o   Pathology

o   Radiology

o   Chest and Lung

o   Neurology

o   Others

• India AI in Medical Diagnostics Market, By Region:

o   East India

o   West India

o   North India

o   South India

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the India AI in Medical Diagnostics Market.

Available Customizations:

India AI in Medical Diagnostics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

India AI in Medical Diagnostics Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]